Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway

Prostaglandins and Other Lipid Mediators

Volumn 118-119, Issue , 2015, Pages 19-27

  Chu, Ling Yun ^a   Liou, Jun Yang ^a,b   Wu, Kenneth K ^a,b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

14 3 3; PPAR; Prostacyclin

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CASPASE 3; CYCLIC AMP; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN BAD; PROTEIN KINASE B; ROSIGLITAZONE; THROMBOXANE A2; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

APOPTOSIS; BRAIN ISCHEMIA; CYTOSOL; GENE TRANSFER; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; KERATINOCYTE; NONHUMAN; PLATELET REACTIVITY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; THROMBOCYTE AGGREGATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY; PROTECTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

14-3-3 PROTEINS; ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLATELET AGGREGATION; PROTECTIVE FACTORS; SIGNAL TRANSDUCTION;

EID: 84928943190     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.04.006     Document Type: Review

References (93)

1. S. Bunting, R. Gryglewski, S. Moncada, and J.R. Vane Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation Prostaglandins 12 1976 897 913
2. N. Whittaker, S. Bunting, J. Salmon, S. Moncada, J.R. Vane, and R.A. Johnson The chemical structure of prostaglandin X (prostacyclin) Prostaglandins 12 1976 915 928
3. S. Moncada, R. Gryglewski, S. Bunting, and J.R. Vane An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
4. S. Hara, A. Miyata, C. Yokoyama, H. Inoue, R. Brugger, and F. Lottspeich Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells J Biol Chem 269 1994 19897 19903
5. B. Pereira, K.K. Wu, and L.H. Wang Molecular cloning and characterization of bovine prostacyclin synthase Biochem Biophys Res Commun 203 1994 59 66
6. M. Hecker, and V. Ullrich On the mechanism of prostacyclin and thromboxane A2 biosynthesis J Biol Chem 264 1989 141 150
7. K.K. Wu, and J.Y. Liou Cellular and molecular biology of prostacyclin synthase Biochem Biophys Res Commun 338 2005 45 52
8. K.H. Ruan, H. Deng, J. Wu, and S.P. So The N-terminal membrane anchor domain of the membrane-bound prostacyclin synthase involved in the substrate presentation of the coupling reaction with cyclooxygenase Arch Biochem Biophys 435 2005 372 381
9. N.L. Baenziger, P.R. Becherer, and P.W. Majerus Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts Cell 16 1979 967 974
10. K.K. Wu Inducible cyclooxygenase and nitric oxide synthase Adv Pharmacol 33 1995 179 207
11. J.N. Topper, J. Cai, D. Falb, and M.A. Gimbrone Jr. Identification of vascular endothelia genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress Proc Natl Acad Sci U S A 93 1996 10417 10422
12. B.B. Weksler, C.W. Ley, and E.A. Jaffe Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187 J Clin Invest 62 1978 923 930
13. K. Shroer, Y. Zhu, M.A. Saunders, W.G. Deng, X.M. Xu, and Meyer-Kirchrath Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators Circulation 105 2002 2760 2765
14. K.K. Wu Injury-coupled induction of endothelial eNOS and COX-2 genes: a paradigm for thromboresistant gene therapy Proc Assoc Am Phys 110 1998 163 170
15. B. Samuelsson, M. Goldyne, E. Granström, M. Hamberg, S. Hammarström, and C. Malmsten Prostaglandins and thromboxanes Annu Rev Biochem 47 1978 997 1029
16. K. Ohashi, K.H. Ruan, R.J. Kulmacz, K.K. Wu, and L.H. Wang Primary structure of human thromboxane synthase determined from the cDNA sequence J Biol Chem 267 1992 789 793
17. T. Tanabe, C. Yokoyama, A. Miyata, H. Ihara, T. Kosaka, and K. Suzuki Molecular cloning and expression of human thromboxane synthase J Lipid Mediat 6 1993 139 144
18. S. Moncada, and J.R. Vane Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls N Engl J Med 300 1979 1142 1147
19. Y. Cheng, S.C. Austin, B. Rocca, B.H. Koller, T.M. Coffman, and T. Grosser Role of prostacyclin in the cardiovascular response to thromboxane A2 Science 296 2002 539 541
20. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1999 1193 1226
21. R.R. Gorman, S. Bunting, and O.V. Miller Modulation of human platelet adenylate cyclas by prostacyclin (PGX) Prostaglandins 13 1977 377 388
22. R.D. Rudic, D. Brinster, Y. Cheng, S. Fries, W.L. Song, and S. Austin COX-2-derived prostacyclin modulates vascular remodeling Circ Res 96 2005 1240 1247
23. E. Falcetti, S.M. Hall, P.G. Phillips, J. Patel, N.W. Morrell, and S.G. Haworth Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 182 2010 1161 1170
24. T. Murata, F. Ushikubi, T. Matsuoka, M. Hirata, A. Yamasaki, and Y. Sugimoto Altered pain perception and inflammatory response in mice lacking prostacyclin receptor Nature 388 1997 678 682
25. S.R. Adderley, and D.J. Fitzgerald Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 J Biol Chem 274 1999 5038 5046
26. C.M. Hao, M. Kömhoff, Y. Guan, R. Redha, and M.D. Breyer Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival Am J Physiol 277 1999 F352 F359
27. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
28. S.A. Kliewer, S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, and C.S. Koble Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma Proc Natl Acad Sci U S A 94 1997 4318 4323
29. B.M. Forman, J. Chen, and R.M. Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proc Natl Acad Sci U S A 94 1997 4312 4317
30. J.Y. Liou, S. Lee, D. Ghelani, N. Matijevic-Aleksic, and K.K. Wu Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation Arterioscler Thromb Vasc Biol 26 2006 1481 1487
31. B. Jiang, P. Liang, B. Zhang, X. Huang, and X. Xiao Enhancement of PPAR-beta activity by repetitive low-grade H2O2 stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis Free Radic Biol Med 46 2009 555 563
32. S.P. Nana-Sinkam, J.D. Lee, S. Sotto-Santiago, R.S. Stearman, R.L. Keith, and Q. Choudhury Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke Am J Respir Crit Care Med 175 2007 676 685
33. L.V. d'Uscio, P. Das, A.V. Santhanam, T. He, S.G. Younkin, and Z.S. Katusic Activation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein Cardiovasc Res 96 2012 504 512
34. Z.S. Katusic, A.V. Santhanam, and T. He Vascular effects of prostacyclin: does activation of PPARδ play a role? Trends Pharmacol Sci 33 2012 559 564
35. S.K. Shyue, M.J. Tsai, J.Y. Liou, J.T. Willerson, and K.K. Wu Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer Circulation 103 2001 2090 2095
36. Y.H. Hsu, C.H. Chen, C.C. Hou, Y.M. Sue, C.Y. Cheng, and T.H. Cheng Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalpha-dependent pathway Kidney Int 73 2008 578 587
37. L. Piqueras, A.R. Reynolds, K.M. Hodivala-Dilke, A. Alfranca, J.M. Redondo, and T. Hatae Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis Arterioscler Thromb Vasc Biol 27 2007 63 69
38. Y. Fan, Y. Wang, Z. Tang, H. Zhang, X. Qin, and Y. Zhu Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells Arterioscler Thromb Vasc Biol 28 2008 315 321
39. I. Inoue, K. Hayashi, F. Yagasaki, K. Nakamura, T. Matsunaga, and H. Xu Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor gamma 1 (PPARgamma 1) and PPARalpha genes J Atheroscler Thromb 10 2003 99 108
40. C.H. Yeh, T.P. Chen, C.H. Lee, Y.C. Wu, Y.M. Lin, and P.J. Lin Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators Shock 26 2006 262 270
41. R.A. Roberts, N.H. James, N.J. Woodyatt, N. Macdonald, and J.D. Tugwood Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha) Carcinogenesis 19 1998 43 48
42. A. Tabernero, K. Schoonjans, L. Jesel, I. Carpusca, J. Auwerx, and R. Andriantsitohaina Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury improves endothelial vasodilatation BMC Pharmacol 2 2002 10
43. M.C. Clarke, N. Figg, J.J. Maguire, A.P. Davenport, M. Goddard, and T.D. Littlewood Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis Nat Med 12 2006 1075 1080
44. H. Yu, M.C. Clarke, N. Figg, T.D. Littlewood, and M.R. Bennett Smooth muscle cell apoptosis promotes vessel remodeling and repair via activation of cell migration, proliferation, and collagen synthesis Arterioscler Thromb Vasc Biol 31 2011 2402 2409
45. Y.C. Chen, L.Y. Chu, S.F. Yang, H.L. Chen, S.F. Yet, and K.K. Wu Prostacyclin and PPARα agonists control vascular smooth muscle cell apoptosis and phenotypic switch through distinct 14-3-3 isoforms PLoS ONE 8 2013 e69702
46. J. Aubert, P. Saint-Marc, N. Belmonte, C. Dani, R. Négrel, and G. Ailhaud Prostacyclin IP receptor up-regulates the early expression of C/EBPbeta and C/EBPdelta in preadipose cells Mol Cell Endocrinol 160 2000 149 156
47. G. Lazennec, L. Canaple, D. Saugy, and W. Wahli Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators Mol Endocrinol 14 2000 1962 1975
48. E. Falcetti, D.M. Flavell, B. Staels, A. Tinker, S.G. Haworth, and L.H. Clapp IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues Biochem Biophys Res Commun 360 2007 821 827
49. K.M. Fetalvero, M. Shyu, A.P. Nomikos, Y.F. Chiu, R.J. Wagner, and R.J. Powell The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway Am J Physiol Heart Circ Physiol 290 2006 H1337 H1346
50. Z. Kasza, K.M. Fetalvero, M. Ding, R.J. Wagner, K. Acs, and A.K. Guzman Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation J Mol Cell Cardiol 46 2009 682 694
51. J. Plutzky The PPAR-RXR transcriptional complex in the vasculature: energy in the balance Circ Res 108 2011 1002 1016
52. M. Cherkaoui-Malki, K. Meyer, W.Q. Cao, N. Latruffe, A.V. Yeldandi, and M.S. Rao Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis Gene Expr 9 2001 291 304
53. N. Di-Poï, N.S. Tan, L. Michalik, W. Wahli, and B. Desvergne Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway Mol Cell 10 2002 721 733
54. G. Tzivion, and J. Avruch 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation J Biol Chem 277 2002 3061 3064
55. S.R. Datta, A. Katsov, L. Hu, A. Petros, S.W. Fesik, and M.B. Yaffe 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation Mol Cell 6 2000 41 51
56. S.C. Masters, H. Yang, S.R. Datta, M.E. Greenberg, and H. Fu 14-3-3 inhibits Bad-induced cell death through interaction with serine-136 Mol Pharmacol 60 2001 1325 1331
57. D. Mukherjee, S.E. Nissen, and E.J. Topol Risk of cardiovascular events associated with selective COX-2 inhibitors J Am Med Assoc 286 2001 954 959
58. S.E. Kimmel, J.A. Berlin, M. Reilly, J. Jaskowiak, L. Kishel, and J. Chittams The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin J Am Coll Cardiol 43 2004 985 990
59. J.Y. Liou, C.C. Wu, B.R. Chen, L.B. Yen, and K.K. Wu Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway Mol Pharmacol 74 2008 1399 1406
60. J.Y. Liou, N. Matijevic-Aleksic, S. Lee, and K.K. Wu Prostacyclin inhibits endothelial cell XIAP ubiquitination and degradation J Cell Physiol 212 2007 840
61. H.J. Kim, M.Y. Kim, H. Jin, H.J. Kim, S.S. Kang, and H.J. Kim Peroxisome proliferator-activated receptor δ regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-β1/Smad3 Circ Res 105 2009 16 24
62. L. Mukundan, J.I. Odegaard, C.R. Morel, J.E. Heredia, J.W. Mwangi, and R.R. Ricardo-Gonzalez PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance Nat Med 15 2009 1266 1272
63. S. Fukuhara, A. Sakurai, H. Sano, A. Yamagishi, S. Somekawa, and N. Takakura Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway Mol Cell Biol 25 2005 136 146
64. E. Dejana, E. Tournier-Lasserve, and B.M. Weinstein The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications Dev Cell 16 2009 209 221
65. A.A. Birukova, T. Wu, Y. Tian, A. Meliton, N. Sarich, and X. Tian Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury Eur Respir 41 2013 165 176
66. H.K. Eltzschig, M. Faigle, S. Knapp, J. Karhausen, J. Ibla, and P. Rosenberger Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26 Blood 108 2006 1602 1610
67. D.P. Pearlstein, M.H. Ali, P.T. Mungai, K.L. Hynes, B.L. Gewertz, and P.T. Schumacker Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia Arterioscler Thromb Vasc Biol 22 2002 566 573
68. M. Yamada, Y. Numaguchi, K. Okumura, M. Harada, K. Naruse, and H. Matsui Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat ballon-injured arteries Arterioscler Thromb Vasc Biol 22 2002 256 262
69. Y. Numaguchi, K. Naruse, M. Harada, H. Osanai, S. Mokuno, and K. Murase Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury Arterioscler Thromb Vasc Biol 19 1999 727 733
70. K.M. Van Benthuysen, I.F. McMurtry, and L.D. Horwitz Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro J Clin Invest 79 1987 265 274
71. J.L. Mehta, W.W. Nichols, W.H. Donnelly, D.L. Lawson, and T.G. Saldeen Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion Circ Res 64 1989 43 54
72. P.S. Tsao, N. Aoki, D.J. Lefer, G. Johnson, and A.M. Lefer Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat Circulation 82 1990 1402 1412
73. N.G. Frangogiannis Regulation of the inflammatory response in cardiac repair Circ Res 110 2012 159 173
74. C.D. Collard, and S. Gelman Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury Anesthesiology 94 2001 1133 1138
75. S. Matsuda, T.C. Wen, Y. Karasawa, H. Araki, H. Otsuka, and K. Ishihara Protective effect of a prostaglandin I2 analog, TEI-7165, on ischemic neuronal damage in gerbils Brain Res 769 1997 321 328
76. J.F. Martin, N. Hamdy, J. Nicholl, N. Lewtas, U. Bergvall, and P. Owen Double-blind controlled trial of prostacyclin in cerebral infarction Stroke 16 1985 386 390
77. H. Lin, T.N. Lin, W.M. Cheung, G.M. Nian, P.H. Tseng, and S.F. Chen Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction Circulation 105 2002 1962 1969
78. A. Kapoor, M. Collino, S. Castiglia, R. Fantozzi, and C. Thiemermann Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat Shock 34 2010 117 124
79. H.H. Chen, T.W. Chen, and H. Lin Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury Am J Physiol Renal Physiol 297 2009 F1109 F1118
80. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
81. T.N. Lin, W.M. Cheung, J.S. Wu, J.J. Chen, H. Lin, and J.J. Chen 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury Arterioscler Thromb Vasc Biol 26 2006 481 487
82. J.S. Wu, W.M. Cheung, Y.S. Tsai, Y.T. Chen, W.H. Fong, and H.D. Tsai Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation Circulation 119 2009 1124 1134
83. J.S. Wu, T.N. Lin, and K.K. Wu Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins J Cell Physiol 220 2009 58 71
84. K. Okahara, B. Sun, and J. Kambayashi Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells Arterioscler Thromb Vasc Biol 18 1998 1922 1926
85. P.S. Tsao, N.P. Lewis, S. Alpert, and J.P. Cooke Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide Circulation 92 1995 3513 3519
86. M. Gomberg-Maitland, and H. Olschewski Prostacyclin therapies for the treatment of pulmonary arterial hypertension Eur Respir J 31 2008 891 901
87. L.J. Rubin, J. Mendoza, M. Hood, M. McGoon, R. Barst, and W.B. Williams Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial Ann Intern Med 112 1990 485 491
88. L.H. Clapp, P. Finney, S. Turcato, S. Tran, L.J. Rubin, and A. Tinker Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery Am J Respir Cell Mol Biol 26 194 2002 201
89. J. Yang, X. Li, R.S. Al-Lamki, M. Southwood, J. Zhao, and A.M. Lever Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo Circ Res 107 2010 252 262
90. J. Wharton, N. Davie, P.D. Upton, M.H. Yacoub, J.M. Polak, and N.W. Morrell Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells Circulation 102 2000 3130 3136
91. T.M. Loosemore, T.C. Chalmers, and J.A. Dormandy A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease Int Angiol 13 1994 133 142
92. P. Zoldhelyi, J. McNatt, X.M. Xu, D. Loose-Mitchell, R.S. Meidell, and F.J. Clubb Jr. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene Circulation 93 1996 10 17
93. H.H. Cheng, C.C. Kuo, J.L. Yan, H.L. Chen, W.C. Lin, and K.H. Wang Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoyxtryptophan Proc Natl Acad Sci U S A 109 2012 13231 13236